Skip to main content
. 2022 Dec 2;188(7-8):e2629–e2638. doi: 10.1093/milmed/usac362

TABLE II.

Primary Outcomes

Parameter Sargramostim arm SOC arm P-value
P(A–a)O2, patients with both baseline and post-baseline, up-to-day 6, n 63 33
Baseline P(A–a)O2, mean (SD), mmHg 299.4 (183.5) 326.0 (172.2)
Post-baseline P(A–a)O2, up-to-day 6, mean (SD), mmHg 199.5 (196.3) 290.8 (212.5)
Change from baseline P(A–a)O2, up-to-day 6, LS mean (SE), mmHg −102.3 (19.4) −30.5 (26.9) .033
LS mean (SE) difference, mmHg −71.7 (33.2)
95% CI of LS mean difference, mmHg −137.7 to −5.8
Percentage change from baseline P(A–a)O2, up-to-day 6, mean (SD)a −30.9 (72.0) −5.2 (91.0)
Patients with improvement of P(A–a)O2
Any improvement, n (%) 53 (84.1) 21 (63.6) .023
≥50% improvement, n (%) 33 (52.4) 10 (30.3) .039
≥33% improvement, n (%) 37 (58.7) 15 (45.5) .22
Patients with intubation (mechanical ventilation) by day 14, n/N (%) 9/78 (11.5) 7b/44 (15.9) .49

Abbreviations: ECMO = extracorporeal membrane oxygenation; LS = least squares; P(A–a)O2 = alveolar–arterial oxygen gradient; SE = standard error; SOC = standard of care.

Primary outcomes are in bold.

a

The percent change in P(A–a)O2 was calculated for each patient as the change from baseline divided by the baseline value. Then, summary statistics were generated.

b

Two patients also received ECMO.